{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:37:40Z","timestamp":1789623460330,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12185-020-02840-x","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T07:02:50Z","timestamp":1583218970000},"page":"118-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Progressive multifocal leukoencephalopathy after CAR T therapy"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-343X","authenticated-orcid":false,"given":"Konstantinos","family":"Sdrimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Diaz-Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros J.","family":"Lekakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"issue":"5","key":"2840_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","volume":"17","author":"EO Major","year":"2018","unstructured":"Major EO, Yousry TA, Clifford DB. Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol. 2018;17(5):467\u201380.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2840_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"CS Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425\u201337.","journal-title":"Lancet Neurol"},{"key":"2840_CR3","doi-asserted-by":"publisher","first-page":"A1432","DOI":"10.1164\/rccm.201412-2148OC","volume":"191","author":"GS Chery","year":"2015","unstructured":"Chery GS, Palmer SM, Snyder LD, Todd JL, Wolfe C. Brincidofovir in progressive multifocal leukoencephalopathy after lung transplant. Am J Respir Crit Care Med. 2015;191:A1432.","journal-title":"Am J Respir Crit Care Med"},{"key":"2840_CR4","doi-asserted-by":"crossref","first-page":"P5\u2013380","DOI":"10.1212\/WNL.90.15_supplement.P5.380","volume":"90","author":"S Eckert","year":"2018","unstructured":"Eckert S, Weinstock-Guttman B, Kolb C, Hojnacki D (2018) Treatment of natalizumab induced PML with cidofovir or CMX001 (brincidofovir) and mirtazapine. Neurology 90:P5\u2013380","journal-title":"Neurology"},{"key":"2840_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","volume":"338","author":"ODH Hall","year":"1998","unstructured":"Hall ODH, Dafni RD, Patricia P, Wetherill EW, McArthur CA, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with HIV infection. N Engl J Med. 1998;338:1345\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"2840_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/713831540","volume":"9","author":"W Royal","year":"2003","unstructured":"Royal W, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol. 2003;9(3):411\u20139.","journal-title":"J Neurovirol"},{"issue":"11","key":"2840_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJM200503173521125","volume":"352","author":"JW Williams","year":"2005","unstructured":"Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005;352(11):1157\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"2840_CR8","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009;53(5):1840\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"2840_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jns.2012.11.004","volume":"324","author":"Z Kobayashi","year":"2013","unstructured":"Kobayashi Z, Akaza M, Numasawa Y, Ishihara S, Tomimitsu H, Nakamichi K, et al. Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: Report of two Japanese patients without human immunodeficiency virus infection. J Neurol Sci. 2013;324(1\u20132):190\u20134.","journal-title":"J Neurol Sci"},{"issue":"6","key":"2840_CR10","first-page":"242","volume":"113","author":"N Epperla","year":"2014","unstructured":"Epperla N, Medina-Flores R, Mazza JJ, Yale SH. Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy. Wis Med J. 2014;113(6):242\u20135.","journal-title":"Wis Med J"},{"issue":"11","key":"2840_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","volume":"361","author":"W Wenning","year":"2009","unstructured":"Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. 2009;361(11):1075\u201380.","journal-title":"N Engl J Med"},{"issue":"17","key":"2840_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMe1904140","volume":"380","author":"IJ Koralnik","year":"2019","unstructured":"Koralnik IJ. Can immune checkpoint inhibitors keep JC virus in check? N Engl J Med. 2019;380(17):1667\u20138.","journal-title":"N Engl J Med"},{"key":"2840_CR13","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","volume":"379","author":"M Muftuoglu","year":"2018","unstructured":"Muftuoglu M, Olson A, Marin D, et al. Allogeneic BK virus-specific T cells for progressive multifocal leukoencephalopathy. N Engl J Med. 2018;379:1443\u2013511.","journal-title":"N Engl J Med"},{"issue":"7","key":"2840_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/jnci\/djz017","volume":"11","author":"BD Hunter","year":"2019","unstructured":"Hunter BD, Jacobson CA. CAR T-cell associated neurotoxicity: mechanisms, clinicopathologic correlates, and future directions. JNCI J Natl Cancer Inst. 2019;11(7):646\u201354.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"26","key":"2840_CR15","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","volume":"127","author":"JN Brudno","year":"2016","unstructured":"Brudno JN, Kochenderfer JN. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood. 2016;127(26):3321\u201330.","journal-title":"Blood"},{"issue":"1","key":"2840_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-018-0629-x","volume":"11","author":"D Kasakovski","year":"2018","unstructured":"Kasakovski D, Xu L, Li Y. T cell senescence and CAR-T cell exhaustion in hematological malignancies. J Hematol Oncol. 2018;11(1):91.","journal-title":"J Hematol Oncol"},{"issue":"1\u20132","key":"2840_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cellimm.2014.02.007","volume":"288","author":"T Kato","year":"2014","unstructured":"Kato T, Nishida T, Ito Y, Murase M, Murata M, Naoe T. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation. Cell Immunol. 2014;288(1\u20132):53\u20139.","journal-title":"Cell Immunol"},{"issue":"2","key":"2840_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13365-019-00738-x","volume":"25","author":"E Hoang","year":"2019","unstructured":"Hoang E, Bartlett NL, Goyal MS, Schmidt RE, Clifford DB. Progressive multifocal leukoencephalopathy treated with nivolumab. J Neurovirol. 2019;25(2):284\u20137.","journal-title":"J Neurovirol"},{"issue":"17","key":"2840_CR19","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMc1816198","volume":"380","author":"O Walter","year":"2019","unstructured":"Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, et al. Treatment of progressive multifocal leukoencephalopathy with nivolumab. N Engl J Med. 2019;380(17):1674\u20136.","journal-title":"N Engl J Med"},{"issue":"17","key":"2840_CR20","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","volume":"380","author":"I Cortese","year":"2019","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, Ha S-K, Smith B, Monaco M, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019;380(17):1597\u2013605.","journal-title":"N Engl J Med"},{"issue":"3","key":"2840_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/QAI.0b013e31825a313c","volume":"60","author":"CS Tan","year":"2012","unstructured":"Tan CS, Bord E, Broge TA, Glotzbecker B, Mills H, Gheuens S, et al. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acqui Immune Defic Syndr. 2012;60(3):244\u20138.","journal-title":"J Acqui Immune Defic Syndr"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-020-02840-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T13:19:18Z","timestamp":1722518358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-020-02840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02840-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}